3-(4-Chlorobutanoyl)-1H-Indole-5-Carbonitrile Bulk Price 2026: Market Analysis and Procurement Strategy
- 2026 Price Forecast: Stability expected due to optimized synthesis routes and raw material availability.
- Quality Standards: Industrial purity exceeding 98.5% is critical for downstream pharmaceutical applications.
- Strategic Sourcing: Partnering with a verified global manufacturer ensures consistent supply chain reliability.
The pharmaceutical intermediate landscape is evolving rapidly as we approach 2026, with specific focus on key building blocks such as 3-(4-Chlorobutanoyl)-1H-indole-5-carbonitrile (CAS: 276863-95-7). This compound serves as a vital precursor in the synthesis of various kinase inhibitors and oncology therapeutics. For procurement managers and process chemists, understanding the bulk price dynamics is essential for budgeting and long-term supply chain security. As a premier global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. provides detailed insight into the cost drivers and technical specifications required for large-scale production.
Global Bulk Pricing Trends for CAS 276863-95-7 in 2026
Market analysis indicates that the pricing structure for complex indole derivatives will remain relatively stable through 2026, provided that supply chains for key starting materials remain uninterrupted. The bulk price is primarily influenced by the cost of 5-cyanoindole and 4-chlorobutyryl chloride, alongside energy costs associated with the acylation reaction. Manufacturers who have optimized their reaction conditions to improve yields can offer more competitive rates without compromising on quality.
Procurement strategies should account for potential fluctuations in solvent costs and regulatory compliance fees. However, established supply chains mitigate these risks. When evaluating quotes, buyers must look beyond the unit cost and consider the total cost of ownership, which includes purity levels and the reliability of the Certificate of Analysis (COA). A lower price point often correlates with inferior purification steps, which can lead to costly delays in downstream drug substance manufacturing.
Factors Influencing Wholesale Costs of Pharmaceutical Intermediates
Several technical and economic factors dictate the wholesale cost of this specific intermediate. The primary driver is the efficiency of the synthesis route. Traditional Friedel-Crafts acylation methods require precise temperature control and stoichiometric balancing to minimize side products such as di-acylated species or regioisomers.
Furthermore, the demand for industrial purity significantly impacts production costs. Achieving purity levels above 98.5% often necessitates multiple recrystallization steps or column chromatography on a pilot scale, which increases processing time and solvent consumption. Companies prioritizing high-throughput screening materials may accept lower purity, but GMP-aligned production requires stringent controls.
Another variant often encountered in literature is 3-(4-chlorobutyryl)-1H-indol-5-carbonitrile, which refers to the same chemical entity but highlights the ketone functionality explicitly. Similarly, the nomenclature 3-(4-Chloro-1-oxobutyl)-1H-indole-5-carbonitrile is used in specific regulatory filings. Consistency in naming across procurement documents ensures that the correct specification is sourced, preventing costly mismatches in chemical inventory.
Technical Specifications and Quality Control
To ensure seamless integration into downstream processes, buyers should request detailed impurity profiles. Key parameters include residual solvents, heavy metals, and specific related substances. The table below outlines the typical technical specifications expected for high-grade material suitable for pharmaceutical synthesis.
| Parameter | Specification | Test Method |
|---|---|---|
| Appearance | Off-white to Light Yellow Powder | Visual |
| Purity (HPLC) | ≥ 98.5% | Area Normalization |
| Water Content | ≤ 0.5% | Karl Fischer |
| Residual Solvents | Compliant with ICH Q3C | GC |
| Heavy Metals | ≤ 10 ppm | ICP-MS |
How to Source High-Purity 3-(4-Chlorobutanoyl)indole-5-carbonitrile at Scale
Sourcing this intermediate at scale requires a partner with robust capacity and technical expertise. When evaluating potential suppliers, it is crucial to audit their manufacturing process to ensure scalability and reproducibility. A reliable supplier will provide batch consistency data demonstrating that critical quality attributes remain stable across multiple production runs.
NINGBO INNO PHARMCHEM CO.,LTD. maintains strict quality control protocols to ensure that every batch meets the rigorous demands of the pharmaceutical industry. By controlling the entire production lifecycle, from raw material selection to final packaging, we minimize variability and ensure that the industrial purity standards are consistently met. This level of oversight is critical when scaling from kilogram to tonnage quantities.
Additionally, logistical capabilities play a significant role in sourcing decisions. Proper packaging is required to prevent moisture uptake, which can degrade the chlorobutanoyl moiety over time. Secure shipping protocols ensure that the material arrives at the destination facility with the same specifications as when it left the production plant.
Conclusion and Strategic Recommendation
As the industry moves toward 2026, the demand for high-quality intermediates like 3-(4-chlorobutanoyl)indole-5-carbonitrile will continue to grow. Procurement teams should prioritize partnerships with established entities that offer transparency in their COA documentation and have a proven track record of delivering on time. By focusing on technical excellence and supply chain reliability, pharmaceutical companies can mitigate risks associated with raw material shortages.
For organizations seeking a dependable supply chain partner, NINGBO INNO PHARMCHEM CO.,LTD. stands ready to support your production needs with competitive pricing and uncompromised quality. Secure your supply today to ensure uninterrupted development of your therapeutic pipelines.